Literature DB >> 1153238

Phenylalanine hydroxylase activity in liver biopsies from hyperphenylalaninemia heterozygotes: deviation from proportionality with gene dosage.

S Kaufman, E E Max, E S Kang.   

Abstract

Liver biopsy samples from the patients with hyperphenylalaninemia have an average of 5 percent of the normal hydroxylase activity. The parents of the patients have between 7.3 percent (excluding the value for one parent) and 10 percent of the normal hepatic hydroxylase activity. An explanation for these findings involves negative interallelic complementation, which involves protein-protein interaction between subunits in a multimeric enzyme. In support of this model is the evidence that rat liver phenylalanine hydroxylase is a multimeric protein composed of two electrophoretically distinguishable subunits.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1153238     DOI: 10.1203/00006450-197508000-00004

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  19 in total

Review 1.  The salience of Garrod's 'molecular groupings' and 'Inborn Factors in Disease'.

Authors:  C R Scriver
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

2.  Hepatic phenylalanine hydroxylase activity in hyperphenylalaninaemia.

Authors:  J L Dhondt; J P Farriaux
Journal:  J Inherit Metab Dis       Date:  1981       Impact factor: 4.982

3.  Mutation analysis in families with discordant phenotypes of phenylalanine hydroxylase deficiency. Inheritance and expression of the hyperphenylalaninaemias.

Authors:  P Guldberg; H L Levy; R Koch; C M Berlin; B Francois; K F Henriksen; F Güttler
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

4.  Aberrant phenylalanine metabolism in phenylketonuria heterozygotes.

Authors:  P Guldberg; K F Henriksen; H C Lou; F Güttler
Journal:  J Inherit Metab Dis       Date:  1998-06       Impact factor: 4.982

5.  Significant phenylalanine hydroxylation in vivo in patients with classical phenylketonuria.

Authors:  G N Thompson; D Halliday
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

Review 6.  Clinical application of genotypic diagnosis for phenylketonuria: theoretical considerations.

Authors:  F D Ledley
Journal:  Eur J Pediatr       Date:  1991-09       Impact factor: 3.183

7.  PAH deficiency in Italy: correlation of genotype with phenotype in the Sicilian population.

Authors:  V Romano; P Guldberg; F Güttler; C Meli; F Mollica; L Pavone; M Giovannini; E Riva; G Biasucci; D Luotti; L Palillo; F Calí; N Ceratto; G Anello; P Bosco
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

8.  Hyperphenylalaninemia due to deficiency of 6-pyruvoyl tetrahydropterin synthase. Unusual gene dosage effect in heterozygotes.

Authors:  C R Scriver; C L Clow; P Kaplan; A Niederwieser
Journal:  Hum Genet       Date:  1987-10       Impact factor: 4.132

9.  Tetrahydrobiopterin deficiency: assay for 6-pyruvoyl-tetrahydropterin synthase activity in erythrocytes, and detection of patients and heterozygous carriers.

Authors:  H Shintaku; A Niederwieser; W Leimbacher; H C Curtius
Journal:  Eur J Pediatr       Date:  1988-01       Impact factor: 3.183

10.  The genetic linkage between the PKU locus and the loci for amylase 1, amylase 2, Fy, PGM 1, and Rh and the question of assignment of the PKU locus to chromosome no. 1.

Authors:  A Knapp; R Tintschewa; E Scheibe; E Scheibe; B Jäger; K E Biebler
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.